{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:07:18Z","timestamp":1648678038825},"reference-count":8,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1586\/14737175.1.1.28","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T15:34:53Z","timestamp":1105630493000},"page":"28-32","source":"Crossref","is-referenced-by-count":1,"title":["IM olanzapine in the treatment of agitation and aggression"],"prefix":"10.1586","volume":"1","author":[{"given":"Elizabeth A","family":"Winans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G","family":"Janicak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"issue":"1","key":"CIT0001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002512-200118010-00004","volume":"18","author":"Byerly MJ","year":"2001","journal-title":"Drug Aging"},{"issue":"7","key":"CIT0002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3928\/0048-5713-19980701-09","volume":"28","author":"Winans EA","year":"1998","journal-title":"Psych. Ann"},{"key":"CIT0006","unstructured":"Breier A, Wright P, Birkett M, et al. Intramuscular olanzapine: dose-related improvement in acutely agitated patients with schizophrenia. Proceedings of the American Psychiatric Association. New Orleans, USA, (2001)."},{"key":"CIT0007","first-page":"79","volume":"45","author":"Baldessarini RJ","year":"1988","journal-title":"Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch. Gen. Psychiatry"},{"key":"CIT0008","first-page":"1149","volume":"158","author":"Wright P","year":"2001","journal-title":"Double- blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am. j Porhiatry"},{"key":"CIT0009","unstructured":"Meehan K, Zhang F, Davis SR et al. Intramuscular olanzapine: efficacy andsafety in acutely agitated patients with mania associated with bipolar disorder. Proceedings of the American Psychiatric Association. New Orleans, USA, (2001)."},{"issue":"4","key":"CIT0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","volume":"21","author":"Meehan K","year":"2001","journal-title":"Psychopharmacol"},{"key":"CIT0011","unstructured":"Meehan KM, Wang H, Davis SR eta] Intramuscular olanzapine: efficacy and safety in acutely agitated patients with dementia. Proceedings of the American Psychiatric Association. New Orleans, USA, (2001)."}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737175.1.1.28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T03:38:00Z","timestamp":1547437080000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737175.1.1.28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1586\/14737175.1.1.28"],"URL":"https:\/\/doi.org\/10.1586\/14737175.1.1.28","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}